These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 33254988

  • 1. Biomimetic micellar mesoporous silica xerogel performs superior nitrendipine dissolution, systemic stability and cellular transmembrane transport.
    Jiang Q, Wu L, Zheng Y, Xia X, Zhang P, Lu T, Li J.
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111372. PubMed ID: 33254988
    [Abstract] [Full Text] [Related]

  • 2. Preparation of a Mesoporous Structure of SnO2 for Increasing the Oral Bioavailability and Dissolution Rate of Nitrendipine.
    Liu X, Wu C, Bai A, Lv H, Xu X, Cao Y, Shang W, Hu L, Liu Y.
    AAPS PharmSciTech; 2018 Oct; 19(7):3228-3236. PubMed ID: 30187447
    [Abstract] [Full Text] [Related]

  • 3. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: Superiority of amino modification.
    Li J, Xu L, Wang H, Yang B, Liu H, Pan W, Li S.
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():710-716. PubMed ID: 26652425
    [Abstract] [Full Text] [Related]

  • 4. Superiority of biomimetic micelle-entrapped nanoporous silica xerogel to deliver poorly water-soluble itraconazole.
    Li X, Li D, Liu Z.
    RSC Adv; 2022 Oct 04; 12(44):28422-28432. PubMed ID: 36320489
    [Abstract] [Full Text] [Related]

  • 5. Biomimetic synthesized nanoporous silica@poly(ethyleneimine)s xerogel as drug carrier: characteristics and controlled release effect.
    Li J, Xu L, Liu H, Wang Y, Wang Q, Chen H, Pan W, Li S.
    Int J Pharm; 2014 Jun 05; 467(1-2):9-18. PubMed ID: 24674897
    [Abstract] [Full Text] [Related]

  • 6. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine.
    Li H, Li H, Wei C, Ke J, Li J, Xu L, Liu H, YangYang, Li S, Yang M.
    Eur J Pharm Sci; 2018 May 30; 117():321-330. PubMed ID: 29530545
    [Abstract] [Full Text] [Related]

  • 7. Biomimetic synthesized chiral mesoporous silica: Structures and controlled release functions as drug carrier.
    Li J, Xu L, Yang B, Bao Z, Pan W, Li S.
    Mater Sci Eng C Mater Biol Appl; 2015 Oct 30; 55():367-72. PubMed ID: 26117767
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P, Mäkilä E, Heikkilä T, Salonen J, Hirvonen J, Santos HA.
    Int J Pharm; 2011 Jul 29; 414(1-2):148-56. PubMed ID: 21601623
    [Abstract] [Full Text] [Related]

  • 10. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D, Mužík J, Šoltys M, Beránek J, Kazarian SG, Štěpánek F.
    Eur J Pharm Biopharm; 2018 Sep 29; 130():327-335. PubMed ID: 30012403
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state.
    Weerapol Y, Limmatvapirat S, Jansakul C, Takeuchi H, Sriamornsak P.
    Eur J Pharm Biopharm; 2015 Apr 29; 91():25-34. PubMed ID: 25615879
    [Abstract] [Full Text] [Related]

  • 14. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH, Smått JH, Govardhanam NP, Ibrahim HM, Ismael HR, Afouna MI, Samy AM, Rosenholm JM.
    Eur J Pharm Sci; 2020 Jan 15; 142():105103. PubMed ID: 31648050
    [Abstract] [Full Text] [Related]

  • 15. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A, Hamidi M.
    Expert Opin Drug Deliv; 2016 Jan 15; 13(2):171-81. PubMed ID: 26636904
    [Abstract] [Full Text] [Related]

  • 16. How biomimetic amino modified mesoporous silica xerogel regulates loading and in vitro sustained delivery of levorotary ofloxacin.
    Zhang P, Lu T, Xia X, Wu L, Shao L, Zhou J, Li J.
    Mater Sci Eng C Mater Biol Appl; 2020 Feb 15; 107():110266. PubMed ID: 31761238
    [Abstract] [Full Text] [Related]

  • 17. Supersaturation Potential of Ordered Mesoporous Silica Delivery Systems. Part 1: Dissolution Performance and Drug Membrane Transport Rates.
    Dening TJ, Taylor LS.
    Mol Pharm; 2018 Aug 06; 15(8):3489-3501. PubMed ID: 29985627
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antioxidant properties of probucol released from mesoporous silica.
    Lau M, Giri K, Garcia-Bennett AE.
    Eur J Pharm Sci; 2019 Oct 01; 138():105038. PubMed ID: 31398394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.